1	Phenylarsine	Phenylarsine	_	_	_	_	_	_	_
2	oxide	oxide	_	_	_	_	_	_	_
3	inhibits	inhibit	_	_	_	_	_	_	_
4	ex	ex	_	_	_	_	_	_	_
5	vivo	vivo	_	_	_	_	_	_	_
6	HIV-1	HIV-1	_	_	_	_	_	_	_
7	expression	expression	_	_	_	_	_	_	_
8	.	.	_	_	_	_	_	_	_

1	Phenylarsine	Phenylarsine	_	_	_	_	_	_	_
2	oxide	oxide	_	_	_	_	_	_	_
3	(	(	_	_	_	_	_	_	_
4	PAO	PAO	_	_	_	_	_	_	_
5	)	)	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	which	which	_	_	_	_	_	_	_
8	is	be	_	_	_	_	_	_	_
9	described	describe	_	_	_	_	_	_	_
10	as	as	_	_	_	_	_	_	_
11	an	an	_	_	_	_	_	_	_
12	inhibitor	inhibitor	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	tyrosine	tyrosine	_	_	_	_	_	_	_
15	phosphatase	phosphatase	_	_	_	_	_	_	_
16	activity	activity	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	inhibits	inhibit	_	_	_	_	_	_	_
19	H2O2	h2o2	_	_	_	_	_	_	_
20	release	release	_	_	_	_	_	_	_
21	from	from	_	_	_	_	_	_	_
22	human	human	_	_	_	_	_	_	_
23	peripheral	peripheral	_	_	_	_	_	_	_
24	blood	blood	_	_	_	_	_	_	_
25	mononuclear	mononuclear	_	_	_	_	_	_	_
26	cells	cell	_	_	_	_	_	_	_
27	(	(	_	_	_	_	_	_	_
28	PBMCs	PBMC	_	_	_	_	_	_	_
29	)	)	_	_	_	_	_	_	_
30	as	as	_	_	_	_	_	_	_
31	measured	measure	_	_	_	_	_	_	_
32	by	by	_	_	_	_	_	_	_
33	electrochemistry	electrochemistry	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	Since	since	_	_	_	_	_	_	_
2	human	human	_	_	_	_	_	_	_
3	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
4	virus	virus	_	_	_	_	_	_	_
5	type	type	_	_	_	_	_	_	_
6	1	1	_	_	_	_	_	_	_
7	(	(	_	_	_	_	_	_	_
8	HIV-1	HIV-1	_	_	_	_	_	_	_
9	)	)	_	_	_	_	_	_	_
10	replication	replication	_	_	_	_	_	_	_
11	is	be	_	_	_	_	_	_	_
12	known	know	_	_	_	_	_	_	_
13	to	to	_	_	_	_	_	_	_
14	be	be	_	_	_	_	_	_	_
15	favored	favor	_	_	_	_	_	_	_
16	under	under	_	_	_	_	_	_	_
17	oxidative	oxidative	_	_	_	_	_	_	_
18	stress	stress	_	_	_	_	_	_	_
19	conditions	condition	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	ex	ex	_	_	_	_	_	_	_
22	vivo	vivo	_	_	_	_	_	_	_
23	experiments	experiment	_	_	_	_	_	_	_
24	using	use	_	_	_	_	_	_	_
25	uninfected	uninfected	_	_	_	_	_	_	_
26	PBMCs	pbmc	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	primary	primary	_	_	_	_	_	_	_
29	monocytes	monocyte	_	_	_	_	_	_	_
30	or	or	_	_	_	_	_	_	_
31	a	a	_	_	_	_	_	_	_
32	latently	latently	_	_	_	_	_	_	_
33	infected	infected	_	_	_	_	_	_	_
34	promonocytic	promonocytic	_	_	_	_	_	_	_
35	U1	u1	_	_	_	_	_	_	_
36	cell	cell	_	_	_	_	_	_	_
37	line	line	_	_	_	_	_	_	_
38	show	show	_	_	_	_	_	_	_
39	that	that	_	_	_	_	_	_	_
40	HIV-1	HIV-1	_	_	_	_	_	_	_
41	replication	replication	_	_	_	_	_	_	_
42	and	and	_	_	_	_	_	_	_
43	reactivation	reactivation	_	_	_	_	_	_	_
44	,	,	_	_	_	_	_	_	_
45	monitored	monitor	_	_	_	_	_	_	_
46	by	by	_	_	_	_	_	_	_
47	p24	p24	_	_	_	_	_	_	_
48	antigen	antigen	_	_	_	_	_	_	_
49	measurement	measurement	_	_	_	_	_	_	_
50	,	,	_	_	_	_	_	_	_
51	are	be	_	_	_	_	_	_	_
52	inhibited	inhibit	_	_	_	_	_	_	_
53	by	by	_	_	_	_	_	_	_
54	PAO	PAO	_	_	_	_	_	_	_
55	in	in	_	_	_	_	_	_	_
56	a	a	_	_	_	_	_	_	_
57	time-	time-	_	_	_	_	_	_	_
58	and	and	_	_	_	_	_	_	_
59	concentration-dependent	concentration-dependent	_	_	_	_	_	_	_
60	manner	manner	_	_	_	_	_	_	_
61	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	observations	observation	_	_	_	_	_	_	_
3	can	can	_	_	_	_	_	_	_
4	be	be	_	_	_	_	_	_	_
5	linked	link	_	_	_	_	_	_	_
6	with	with	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	inhibition	inhibition	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	NF-kappa	NF-kappa	_	_	_	_	_	_	_
11	B	B	_	_	_	_	_	_	_
12	activation	activation	_	_	_	_	_	_	_
13	when	when	_	_	_	_	_	_	_
14	uninfected	uninfected	_	_	_	_	_	_	_
15	monocytes	monocyte	_	_	_	_	_	_	_
16	are	be	_	_	_	_	_	_	_
17	induced	induce	_	_	_	_	_	_	_
18	by	by	_	_	_	_	_	_	_
19	either	either	_	_	_	_	_	_	_
20	tumor	tumor	_	_	_	_	_	_	_
21	necrosis	necrosis	_	_	_	_	_	_	_
22	factor	factor	_	_	_	_	_	_	_
23	alpha	alpha	_	_	_	_	_	_	_
24	(	(	_	_	_	_	_	_	_
25	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
26	)	)	_	_	_	_	_	_	_
27	phorbol	phorbol	_	_	_	_	_	_	_
28	12-myristate	12-myristate	_	_	_	_	_	_	_
29	13-acetate	13-acetate	_	_	_	_	_	_	_
30	(	(	_	_	_	_	_	_	_
31	PMA	PMA	_	_	_	_	_	_	_
32	)	)	_	_	_	_	_	_	_
33	or	or	_	_	_	_	_	_	_
34	lipopolysaccharide	lipopolysaccharide	_	_	_	_	_	_	_
35	(	(	_	_	_	_	_	_	_
36	LPS	LPS	_	_	_	_	_	_	_
37	)	)	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

